J J Breton - JoVE Visualize

Showing results (11-20 of 22) with videos related to

Pageof 3

Sort By:

Journal of the American Academy of Child and Adolescent Psychiatry|November 11, 1998

Diagnostic Interview Schedule for Children (DISC-2.25) in Quebec: reliability findings in light of the MECA studyJ J Breton, L Bergeron, J P Valla, et al.

Journal of the American Academy of Child and Adolescent Psychiatry|July 1, 1995

Do children aged 9 through 11 years understand the DISC Version 2.25 questions?J J Breton, L Bergeron, J P Valla, et al.

Cell Biology International|November 1, 1996

Production of biologically active human RelA (p65) in baculovirus-infected insect cellsM Chabot-Fletcher, M L Ho, J J Breton, et al.

Drugs Under Experimental and Clinical Research|January 1, 1993

Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha productionD E Griswold, L M Hillegass, J J Breton, et al.

Journal of Abnormal Child Psychology|April 20, 2000

Correlates of mental disorders in the Quebec general population of 6 to 14-year oldsL Bergeron, J P Valla, J J Breton, et al.

Tumori|October 31, 1992

Weekly first-line chemotherapy of metastatic breast cancer with cyclophosphamide and epirubicinE Alba, E Blanco, E Aranda, et al.

Journal of Child Psychology and Psychiatry, and Allied Disciplines|April 6, 1999

Quebec child mental health survey: prevalence of DSM-III-R mental health disordersJ J Breton, L Bergeron, J P Valla, et al.

The Biochemical Journal|March 24, 2000

Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cellsR C Gardner, S J Assinder, G Christie, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995

Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthmaM C Chabot-Fletcher, D C Underwood, J J Breton, et al.

Journal of Medicinal Chemistry|December 20, 1996

Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)ureaJ L Adams, R S Garigipati, M Sorenson, et al.

Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:

Pageof 3

Journal of the American Academy of Child and Adolescent Psychiatry|November 11, 1998

Diagnostic Interview Schedule for Children (DISC-2.25) in Quebec: reliability findings in light of the MECA studyJ J Breton, L Bergeron, J P Valla, et al.

Journal of the American Academy of Child and Adolescent Psychiatry|July 1, 1995

Do children aged 9 through 11 years understand the DISC Version 2.25 questions?J J Breton, L Bergeron, J P Valla, et al.

Cell Biology International|November 1, 1996

Production of biologically active human RelA (p65) in baculovirus-infected insect cellsM Chabot-Fletcher, M L Ho, J J Breton, et al.

Drugs Under Experimental and Clinical Research|January 1, 1993

Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha productionD E Griswold, L M Hillegass, J J Breton, et al.

Journal of Abnormal Child Psychology|April 20, 2000

Correlates of mental disorders in the Quebec general population of 6 to 14-year oldsL Bergeron, J P Valla, J J Breton, et al.

Tumori|October 31, 1992

Weekly first-line chemotherapy of metastatic breast cancer with cyclophosphamide and epirubicinE Alba, E Blanco, E Aranda, et al.

Journal of Child Psychology and Psychiatry, and Allied Disciplines|April 6, 1999

Quebec child mental health survey: prevalence of DSM-III-R mental health disordersJ J Breton, L Bergeron, J P Valla, et al.

The Biochemical Journal|March 24, 2000

Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cellsR C Gardner, S J Assinder, G Christie, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995

Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthmaM C Chabot-Fletcher, D C Underwood, J J Breton, et al.

Journal of Medicinal Chemistry|December 20, 1996

Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)ureaJ L Adams, R S Garigipati, M Sorenson, et al.

Pageof 3